Agile Therapeutics (AGRX)

Agile Therapeutics (AGRX) Financial Statements


Agile Therapeutics Financial Overview

Agile Therapeutics's market cap is currently ―. The company's EPS TTM is $-14.941; its P/E ratio is -0.01; Agile Therapeutics is scheduled to report earnings on May 8, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 3.00M$ 2.13M$ 1.76M$ 1.51M$ 1.29M
Gross Profit$ 1.58M$ -105.00K$ 234.00K$ -4.19M$ -1.42M
EBIT$ -18.66M$ -11.40M$ -15.57M$ -22.36M$ -15.77M
EBITDA$ -18.40M$ -10.80M$ -14.98M$ -21.78M$ -15.22M
Net Income Common Stockholders$ -19.67M$ -12.22M$ -11.77M$ -23.36M$ -16.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.14M$ 13.03M$ 3.74M$ 19.14M$ 14.73M
Total Assets$ 18.46M$ 32.83M$ 29.30M$ 39.33M$ 36.68M
Total Debt$ 2.15M$ 13.50M$ 13.19M$ 17.79M$ 16.47M
Net Debt$ -4.00M$ 472.00K$ 9.45M$ -1.35M$ 1.74M
Total Liabilities$ 12.20M$ 29.41M$ 26.56M$ 30.06M$ 26.00M
Stockholders Equity$ 6.26M$ 3.42M$ 2.74M$ 9.27M$ 10.68M
Cash Flow-
Free Cash Flow$ -16.70M$ -2.94M$ -14.88M$ -16.67M$ -18.64M
Operating Cash Flow$ -16.70M$ -2.93M$ -14.75M$ -16.62M$ -18.58M
Investing Cash Flow$ 0.00$ -7.00K$ -126.00K$ -55.00K$ 4.93M
Financing Cash Flow$ 9.82M$ 12.22M$ -523.00K$ 21.08M$ 2.26M
Currency in USD

Agile Therapeutics Earnings and Revenue History

Agile Therapeutics Debt to Assets

Agile Therapeutics Cash Flow

Agile Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis